Detalles de la búsqueda
1.
Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?
Circulation
; 148(9): 732-749, 2023 08 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37366061
2.
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
Eur Heart J
; 44(8): 668-677, 2023 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36632831
3.
Stroke in patients with heart failure and reduced or preserved ejection fraction.
Eur Heart J
; 44(31): 2998-3013, 2023 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37358785
4.
Revisiting Race and the Benefit of RAS Blockade in Heart Failure: A Meta-Analysis of Randomized Clinical Trials.
JAMA
; 2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38809561
5.
Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial.
Circulation
; 145(3): 158-169, 2022 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34743554
6.
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF.
Circulation
; 143(4): 298-309, 2021 01 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33040613
7.
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
N Engl J Med
; 381(17): 1609-1620, 2019 10 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31475794
8.
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
N Engl J Med
; 381(21): 1995-2008, 2019 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31535829
9.
Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.
Eur Heart J
; 42(36): 3741-3752, 2021 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34392331
10.
Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF.
Circulation
; 142(11): 1040-1054, 2020 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32673497
11.
Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF.
Circulation
; 141(5): 338-351, 2020 02 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31736337
12.
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF).
Eur Heart J
; 41(36): 3402-3418, 2020 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32820334
13.
Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies.
Circulation
; 138(1): 80-98, 2018 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29967232
14.
Heart Failure With Preserved Ejection Fraction in the Young.
Circulation
; 138(24): 2763-2773, 2018 12 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30565987
15.
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis.
Circulation
; 137(3): 286-297, 2018 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29335288
16.
Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).
Circulation
; 135(8): 724-735, 2017 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28052977
17.
Correction: Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.
PLoS Med
; 15(5): e1002583, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29799848
18.
Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.
PLoS Med
; 15(3): e1002541, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29584721
19.
A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trial.
Am Heart J
; 199: 51-58, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29754666
20.
Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure Trial.
J Card Fail
; 24(5): 303-309, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28918108